Gilead Sciences Inc (NYSE:GILD) under-valued by 7%
Website | https://www.gilead.com/ |
Sector | Healthcare |
Industry | Drug Manufacturers General |
Fiscal Year End | Dec 31, 2021 |
Market Cap | $85,911,330,816 |
Beta | 0.39893 |
Average Volume | $7,741,875 |
Last Dividend | 2.75% |
Price on Dec 31, 2021 | $68.47 |
Autochartist™ Valuation | $73.54 |
Conclusion |
7% under-valued |
Download Report |